Sage Journals: Discover world-class research

Open access

Research article

First published 2018

The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils

Lee Josephson, Nancy Stratman, YuTing Liu [...]

Molecular Imaging

Retricted access

Research article

First published 2020-08

Targeted Alpha Therapy with Thorium-227

Viviana Frantellizzi, Laura Cosma, Gabriele Brunotti [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2020-09

Feasibility of Thorium-227/Radium-223 Gamma-Camera Imaging During Radionuclide Therapy

Erik Larsson, Gustav Brolin, Adriaan Cleton [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2023-02

Radiochemical Quality Control Methods for Radium-223 and Thorium-227 Radiotherapies

Abbie Hasson, Wen Jiang, Nadia Benabdallah [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2001-9

Sink or Swim: What Happened to California's Bilingual Students after Proposition 227?

Valentina A. Bali

State Politics & Policy Quarterly

Open access

Research article

First published 2020-09

Quantitative Dual-Isotope Planar Imaging of Thorium-227 and Radium-223 Using Defined Energy Windows

Iain Murray, Bruno Rojas, Jonathan Gear [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2007-06

Preparation of TH 227 -Labeled Radioimmunoconjugates,Assessment of Serum Stability and Antigen Binding Ability

Roy H. Larsen, Jorgen Borrebaek, Jostein Dahle [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2020-09

Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy

Urs B. Hagemann, Katrine Wickstroem, Stefanie Hammer [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2007-08

Evaluation of the Binding of Radiolabeled Rituximab to CD20-Positive Lymphoma Cells: An In Vitro Feasibility Study Concerning Low-Dose-Rate Radioimmunotherapy with the α -Emitter 227 Th

Katrine B. Melhus, Roy H. Larsen, Trond Stokke [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1976-12

Continued from page 227

Journal of Sociology

Search results